Clinicopathological analyses revealed that an elevated expression of SCIN in glioma patients was linked to an increased WHO grade and a poor survival, moreover, SCIN expression was positively correlated with MMP2 and MMP9 expressions. This evidence concerns the gene MMP2 and glioma.